Avanos Medical, Inc. (AVNS)

Avanos Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-463.2	-392.1	-61.8	50.5	6.3	-29
Depreciation & Amortization	42.4	45.5	43.5	41.2	38.3	42.9
Loss (Gain) From Sale of Assets	1.2	1.2	1.9	1.1	8	23.7
Asset Writedown & Restructuring Costs	513.7	436.7	-	-	-	-
Stock-Based Compensation	14.3	13.8	15.8	15.9	13.2	12.1
Other Operating Activities	-42.3	-39.4	-22.4	-	-3	13.2
Change in Accounts Receivable	14.7	-6.6	39	-24.7	-10.8	45.8
Change in Inventory	44.7	39	4.7	-30.9	15.7	-19.4
Change in Accounts Payable	-2.5	-0.9	-14.4	35.4	-11.9	-18.9
Change in Other Net Operating Assets	-9.6	3.5	-47.3	-4.1	31.5	-72.9
Operating Cash Flow	113.4	100.7	32.4	90.9	87.3	-2.5
Operating Cash Flow Growth	84.09%	210.80%	-64.36%	4.12%	-	-
Capital Expenditures	-25.5	-17.8	-17.8	-19.3	-21	-20.2
Cash Acquisitions	-	-	-49.6	-116.1	-	-4
Divestitures	2.1	2.1	89	-	-	-
Investment in Securities	-16.4	-11.8	-	-	-	-
Investing Cash Flow	-41.9	-27.5	21.6	-135.4	-21	-24.2
Long-Term Debt Issued	-	20	55	400	20	185
Total Debt Issued	-	20	55	400	20	185
Long-Term Debt Repaid	-	-53.6	-119.7	-296.6	-70	-254.8
Total Debt Repaid	-70.2	-53.6	-119.7	-296.6	-70	-254.8
Net Debt Issued (Repaid)	-70.2	-33.6	-64.7	103.4	-50	-69.8
Issuance of Common Stock	1	1.1	1.3	1.7	6.2	3.4
Repurchase of Common Stock	-3.2	-12.8	-19.1	-45.5	-11.5	-0.9
Other Financing Activities	-3.3	-3.8	-11.7	-2.9	-	-2.7
Financing Cash Flow	-75.7	-49.1	-94.2	56.7	-55.3	-70
Foreign Exchange Rate Adjustments	2.3	-4.1	0.2	-3	-4	2.9
Net Cash Flow	-1.9	20	-40	9.2	7	-93.8
Free Cash Flow	87.9	82.9	14.6	71.6	66.3	-22.7
Free Cash Flow Growth	110.29%	467.81%	-79.61%	7.99%	-	-
Free Cash Flow Margin	12.69%	12.05%	2.17%	10.47%	11.29%	-3.18%
Free Cash Flow Per Share	1.91	1.80	0.31	1.51	1.36	-0.47
Cash Interest Paid	11.5	11.5	14.7	8.1	3	16.8
Cash Income Tax Paid	3.3	3.3	23.6	-2.9	-45	-
Levered Free Cash Flow	100.98	107.88	196.13	-85.26	51.3	-41.7
Unlevered Free Cash Flow	107.29	115.5	205.5	-79.01	53.36	-31.95
Change in Working Capital	47.3	35	-18	-24.3	24.5	-65.4

Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q